As the second year of the Covid-19 pandemic unfolds, the United States has entered a new phase of heightened hope in the race to control the outbreak and get ahead of evolving variants. The U.S. government and health sector share an imperative to move quickly to immunize at scale and to address disparities in vaccine access at home and abroad.
Doctor John Rajiv writes a note before receiving his first dose of the Pfizer/BioNTech Covid-19 vaccine in December 2020. | JEFF KOWALSKY/AFP via Getty Images
But public trust and confidence in vaccines, science, and public health authorities are both fragile and absolutely pivotal. What is at stake is fundamentally a matter of national security: achieving herd immunity that truly and rapidly restabilizes public health, economic vitality, and society at large.
Sarita Santoshini Correspondent
When President Joe Biden announced Wednesday that the United States would support a World Trade Organization emergency waiver of COVID-19 vaccine patents, the decision was about more than “the right thing to do.” For some global experts and analysts, the decision reflects something else as well: Mr. Biden’s vision, sharpened over his first three months in office, of reasserting U.S. global leadership.
The larger message the president is sending with the vaccine waiver, some experts say: The coronavirus pandemic is the latest and most urgent in a list of global challenges that will require a strong and complex multilateral response, and the U.S. intends to reclaim the mantle of leader on these issues.
Is Biden administration doing enough for India? Some accuse US, wealthy nations of hoarding COVID-19 vaccines msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Thursday, April 29, 2021 2:00 pm - 3:30 pm
On
Thursday, April 29 from 2:00 – 3:30 p.m. EDT, the CSIS Commission on Strengthening America’s Health Security and CSIS Economics Program will co-host a panel discussion on the major findings of a new Commission report:
Creating Fiscal Space in the Covid-19 Era. This event will feature keynote remarks followed by a distinguished panel of experts, who will discuss innovative, concrete options for generating financial resources for pandemic preparedness and response in low- and middle-income countries (LMICs). The Covid-19 pandemic is a call to action to rethink the roles of official and private sectors in financing pandemic preparedness and response in LMICs with fragile public health systems. The discussion will explore the potential for new approaches to create space for essential investments, leveraging international finance institutions, addressing debt sustainability, and mobilizing new resources to sustain investment in globa
Sheryl Gay Stolberg, The New York Times
Published: 28 Apr 2021 10:53 AM BdST
Updated: 28 Apr 2021 10:53 AM BdST COVID-19 patients receive oxygen at a Sikh gurdwara in Delhi, Sunday, April 25, 2021. President Joe Biden, under intense pressure to do more to address the global coronavirus pandemic, including a humanitarian crisis in India, intends to share up to 60 million doses of the AstraZeneca vaccine with other nations, so long as federal regulators deem the doses safe. (Atul Loke/The New York Times).
President Joe Biden, under intense pressure to do more to address the surging pandemic abroad, including a humanitarian crisis in India, intends to make up to 60 million doses of the AstraZeneca vaccine available to other countries, so long as federal regulators deem the doses safe, officials said Monday.